Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Calcium gluconate 💬1件: Calcium gluconate1件: Calcium gluconate--3件: 214, 215, 235 💬
2 Dapagliflozin 💬1件: Dapagliflozin1件: Dapagliflozin--10件: 6, 28, 49, 66, 67, 86, 88, 215, 218, 222 💬
3 Dexmedetomidine 💬1件: Dexmedetomidine3件: Dexmedetomidina; Dexmedetomidine; Dexmedetomidine hydrochloride3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
4 Dexmedetomidine hydrochloride 💬1件: Dexmedetomidine3件: Dexmedetomidina; Dexmedetomidine; Dexmedetomidine hydrochloride3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
5 Dobutamine 💬1件: Dobutamine2件: Dobutamin; Dobutamine1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 57, 58, 215 💬
6 Dobutamine hydrochloride 💬1件: Dobutamine2件: Dobutamin; Dobutamine1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 57, 58, 215 💬
7 Dobutamine tartrate 💬1件: Dobutamine2件: Dobutamin; Dobutamine1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 57, 58, 215 💬
8 Eplerenone 💬1件: Eplerenone1件: Eplerenone1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215 💬
9 Fentanyl 💬1件: Fentanyl1件: Fentanyl1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 46, 70, 97, 231, 298 💬
10 Fentanyl citrate 💬1件: Fentanyl1件: Fentanyl1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 46, 70, 97, 231, 298 💬
11 Fentanyl hydrochloride 💬1件: Fentanyl1件: Fentanyl1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 46, 70, 97, 231, 298 💬
12 Glutamine 💬1件: L-Glutamine2件: Glutamine; L-glutamine--10件: 87, 89, 96, 97, 113, 214, 215, 222, 245, 299 💬
13 Ketamine 💬1件: Ketamine3件: Ketamine; Ketamine hydrochloride; Nmda5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
14 Ketamine hydrochloride 💬1件: Ketamine3件: Ketamine; Ketamine hydrochloride; Nmda5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
15 Losartan 💬1件: Losartan2件: Losartan; Losartan potassium1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
16 Losartan potassium 💬1件: Losartan2件: Losartan; Losartan potassium1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
17 Propranolol 💬1件: Propranolol3件: Propanolol; Propranolol; Propranolol hydrochloride3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 158, 215, 216, 278, 296 💬
18 Propranolol hydrochloride 💬1件: Propranolol3件: Propanolol; Propranolol; Propranolol hydrochloride3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 158, 215, 216, 278, 296 💬
19 Sodium chloride 💬1件: Sodium chloride2件: Natriumchlorid; Sodium chloride--20件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
20 Sodium citrate 💬1件: Sodium citrate1件: Sodium citrate--4件: 67, 214, 215, 235 💬
21 Sodium citrate hydrate 💬1件: Sodium citrate1件: Sodium citrate--4件: 67, 214, 215, 235 💬
22 Sulfur hexafluoride 💬1件: Sulfur hexafluoride2件: Sulfur hexafluoride; Sulphur hexafluoride--3件: 96, 97, 215 💬
23 Tranexamic acid 💬1件: Tranexamic acid1件: Tranexamic acid1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬8件: 46, 65, 70, 215, 227, 274, 288, 299 💬
24 Ubidecarenone 💬1件: Ubidecarenone2件: Coenzyme Q10; COQ10--13件: 2, 5, 6, 8, 10, 46, 57, 96, 107, 113, 193, 214, 215 💬